胰岛素途径基因表达的酸中介升调表明潜在的抗糖尿病作用
Elad Shapira1,2, Irena Voinsky1, Hana Klin1
1Department of Human Molecular Genetics and Biochemistry, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Drug development research
|November 30, 2025
概括
酸盐是一种肠道微生物的副产品,可以通过对人类细胞中MT2A和INSR等关键基因进行上调来改善2型糖尿病 (T2D). 需要进一步的研究来证实它对胰岛素抵抗的治疗潜力.
科学领域:
- 代谢研究的研究.
- 分子生物学分子生物学
- 微生物组研究的研究.
背景情况:
- 2型糖尿病 (T2D) 是与胰岛素抵抗相关的重大健康问题.
- 由肠道细菌产生的短链脂肪酸酸盐在动物模型中显示出改善T2D症状的前景.
研究的目的:
- 为了研究丁酸盐在人体细胞中的潜在抗糖尿病作用.
- 测量丁酸盐对涉及T2D和胰岛素信号传导的基因转录的影响.
主要方法:
- 从健康的捐赠者获得的人类淋巴细胞细胞系 (LCLs),与或没有甲酸盐进行培养.
- 提取了RNA,并使用实时PCR分析了选择的T2D相关基因的表达.
主要成果:
- 丁酸盐显著提高了MT2A,RRAGD,IGF1R,OXTR和INSR基因的表达.
- 在其他精选的胰岛素信号基因的表达中没有观察到显著的变化.
结论:
- 丁酸盐显示出作为对胰岛素耐药性相关的代谢途径调节者的潜力.
- 这些初步发现表明丁酸盐可能具有治疗作用,因此需要在动物模型和临床试验中进行进一步的研究.
相关概念视频
Insulin: The Receptor and Signaling Pathways
2.7K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.7K
Cell Specific Gene Expression
16.2K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.2K
Insulin Secretory Vesicles
6.3K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones
565
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
565
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
509
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
509
Hormones Regulating Blood Glucose
6.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.3K


